Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C12H16O17Sb2.3Na.H |
Molecular Weight | 745.742 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H+].[Na+].[Na+].[Na+].[H][C@@]1(O[Sb]4([O-])(O[Sb]23([O-])O[C@H]([C@@H](O2)[C@]([H])(O3)[C@H](O)CO)C([O-])=O)O[C@H]([C@H]1O4)C([O-])=O)[C@H](O)CO
InChI
InChIKey=OXXXHEHIUSKLPQ-JZQFZNMZSA-M
InChI=1S/2C6H9O7.3Na.3O.2Sb/c2*7-1-2(8)3(9)4(10)5(11)6(12)13;;;;;;;;/h2*2-5,7-8H,1H2,(H,12,13);;;;;;;;/q2*-3;3*+1;;2*-1;2*+3/p-1/t2*2-,3-,4+,5-;;;;;;;;/m11......../s1
Molecular Formula | Na |
Molecular Weight | 22.9898 |
Charge | 1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | H |
Molecular Weight | 1.0079 |
Charge | 1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C12H16O17Sb2 |
Molecular Weight | 675.765 |
Charge | -4 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:19:02 UTC 2023
by
admin
on
Fri Dec 15 15:19:02 UTC 2023
|
Record UNII |
V083S0159D
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ESSENTIAL MEDICINES LIST |
6.5.2
Created by
admin on Fri Dec 15 15:19:02 UTC 2023 , Edited by admin on Fri Dec 15 15:19:02 UTC 2023
|
||
|
FDA ORPHAN DRUG |
225906
Created by
admin on Fri Dec 15 15:19:02 UTC 2023 , Edited by admin on Fri Dec 15 15:19:02 UTC 2023
|
||
|
WHO-ATC |
P01CB02
Created by
admin on Fri Dec 15 15:19:02 UTC 2023 , Edited by admin on Fri Dec 15 15:19:02 UTC 2023
|
||
|
FDA ORPHAN DRUG |
293609
Created by
admin on Fri Dec 15 15:19:02 UTC 2023 , Edited by admin on Fri Dec 15 15:19:02 UTC 2023
|
||
|
FDA ORPHAN DRUG |
572516
Created by
admin on Fri Dec 15 15:19:02 UTC 2023 , Edited by admin on Fri Dec 15 15:19:02 UTC 2023
|
||
|
WHO-VATC |
QP51AB02
Created by
admin on Fri Dec 15 15:19:02 UTC 2023 , Edited by admin on Fri Dec 15 15:19:02 UTC 2023
|
||
|
NCI_THESAURUS |
C471
Created by
admin on Fri Dec 15 15:19:02 UTC 2023 , Edited by admin on Fri Dec 15 15:19:02 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000084974
Created by
admin on Fri Dec 15 15:19:02 UTC 2023 , Edited by admin on Fri Dec 15 15:19:02 UTC 2023
|
PRIMARY | |||
|
SUB04492MIG
Created by
admin on Fri Dec 15 15:19:02 UTC 2023 , Edited by admin on Fri Dec 15 15:19:02 UTC 2023
|
PRIMARY | |||
|
28148
Created by
admin on Fri Dec 15 15:19:02 UTC 2023 , Edited by admin on Fri Dec 15 15:19:02 UTC 2023
|
PRIMARY | |||
|
8010
Created by
admin on Fri Dec 15 15:19:02 UTC 2023 , Edited by admin on Fri Dec 15 15:19:02 UTC 2023
|
PRIMARY | RxNorm | ||
|
Sodium Stibogluconate
Created by
admin on Fri Dec 15 15:19:02 UTC 2023 , Edited by admin on Fri Dec 15 15:19:02 UTC 2023
|
PRIMARY | |||
|
4020
Created by
admin on Fri Dec 15 15:19:02 UTC 2023 , Edited by admin on Fri Dec 15 15:19:02 UTC 2023
|
PRIMARY | |||
|
SODIUM STIBOGLUCONATE
Created by
admin on Fri Dec 15 15:19:02 UTC 2023 , Edited by admin on Fri Dec 15 15:19:02 UTC 2023
|
PRIMARY | |||
|
V083S0159D
Created by
admin on Fri Dec 15 15:19:02 UTC 2023 , Edited by admin on Fri Dec 15 15:19:02 UTC 2023
|
PRIMARY | |||
|
4158
Created by
admin on Fri Dec 15 15:19:02 UTC 2023 , Edited by admin on Fri Dec 15 15:19:02 UTC 2023
|
PRIMARY | |||
|
C61083
Created by
admin on Fri Dec 15 15:19:02 UTC 2023 , Edited by admin on Fri Dec 15 15:19:02 UTC 2023
|
PRIMARY | |||
|
DB05630
Created by
admin on Fri Dec 15 15:19:02 UTC 2023 , Edited by admin on Fri Dec 15 15:19:02 UTC 2023
|
PRIMARY | |||
|
SODIUM STIBOGLUCONATE
Created by
admin on Fri Dec 15 15:19:02 UTC 2023 , Edited by admin on Fri Dec 15 15:19:02 UTC 2023
|
PRIMARY | Description: A colourless, mostly amorphous powder; odourless. Solubility: Very soluble in water; practically insoluble in ethanol (~750 g/l) TS and ether R. Category: Antileishmaniasis drug. Storage: Sodium stibogluconate should be kept in a well-closed container. Definition: Sodium stibogluconate is a pentavalent antimony compound of indefinite composition. It has been represented by the formula C6H9Na2O9Sb, but it usually contains less than 2 atoms of sodium for each atom of antimony. Sodium stibogluconate contains not less than 30.0% and not more than 34.0% of total antimony, calculated with reference to the dried substance. | ||
|
m1962
Created by
admin on Fri Dec 15 15:19:02 UTC 2023 , Edited by admin on Fri Dec 15 15:19:02 UTC 2023
|
PRIMARY | Merck Index | ||
|
219717-42-7
Created by
admin on Fri Dec 15 15:19:02 UTC 2023 , Edited by admin on Fri Dec 15 15:19:02 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
SOLVATE->ANHYDROUS |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |